HCPLive

JUNE 4, 2024

Follow HCPLive's coverage of the full-day FDA committee meeting regarding Lykos Therapeutics' application for MDMA-assisted therapy as a novel treatment for patients with PTSD.

144

144

American Heart News - Heart News

JUNE 4, 2024

Embargoed until 4 a.m. CT/5 a.m. ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to.

Risk Factors 143

Risk Factors Cardiovascular Disease Blood Pressure Obesity 143

Becker's Hospital Review - Cardiology

JUNE 4, 2024

A majority of adults in the U.S. — around 61% — are likely to be diagnosed with a form of cardiovascular disease by 2050, according to new American Heart Association data. The increased burden will cost the U.S. health system $1.8 trillion in the time frame.

Cardiovascular Disease 124

Cardiovascular Disease 124

Science Daily - Heart Disease

JUNE 4, 2024

Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to cardiovascular disease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S. adults (61%), more than 184 million people, are expected to have some type of CVD within the next 30 years, reflecting a disease prevalence that will have a $1.8 trillion price tag in direct and indirect costs.

Risk Factors 123

Risk Factors Cardiovascular Disease Blood Pressure Obesity 123

DAIC

JUNE 4, 2024

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Image courtesy: Caristo Diagnostics christine.book Tue, 06/04/2024 - 10:00 June 4, 2024 — Caristo Diagnostics Limited , a global provider of cardiovascular disease diagnostics and risk prediction, has announced the results of a landmark clinical stud

Technology 116

Technology Heart attacks Heart Attack Coronary Artery Disease 116

Cardiology Update

JUNE 4, 2024

The DanShock trial (NCT01633502) assessed the efficacy of the Impella CP ventricular assist device in reducing mortality following myocardial infarction (MI). The Impella CP is a catheter-based axial flow pump that directly channels blood from the left ventricle into the circulation, delivering 3.5L/min (approximately 75% of normal cardiac output). Investigators randomized 360 patients to receive either a microaxial flow pump plus standard of care (SOC) (n=179) or SOC alone (n=176).

Cardiogenic Shock 108

Cardiogenic Shock Myocardial Infarction Research Circulation 108

DAIC

JUNE 4, 2024

Stroke recovery is a challenging process that extends for months after hospital discharge. Issues like cognitive impairment and social determinants of health (SDOH) hurdles often go unrecognized until patients are home. To improve outcomes and be in compliance with new regulations, it's crucial to better identify and address these issues during the recovery period.

Stroke 115

Stroke Strokes Innovation Research 115

DAIC

JUNE 4, 2024

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, a

Ultrasound 111

Ultrasound Education Research Nursing 111

HCPLive

JUNE 4, 2024

Our cardiology month in review spotlights the top 5 storylines that defined cardiology during May 2024, including new HCM guidelines, news from ESA 2024, and the FLOW trial.

96

96

DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:51 June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and the Southwest — to undergo a non-surgical, catheter-based procedure with a new type of stroke-prevention stent that eliminates blockages in neck arteries that could potentially cause a deadly stoke by depriving the brain of oxygen.

Stent 111

Stent Stents Research Stroke 111

American Heart News - Stroke News

JUNE 4, 2024

DALLAS, date, 2024 — Significant barriers prevent or slow treatment for many patients with stroke, including long travel times to stroke center hospitals and the lack of availability of stroke specialists who can evaluate the patient and determine if.

Certification 89

Certification Stroke Strokes Hospital 89

DAIC

JUNE 4, 2024

Here is a look at the Top 10 pieces of content viewers were reading during the month of May. 1. American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Med Page Today

JUNE 4, 2024

(MedPage Today) -- FDA reviewers questioned the cardiac safety of midomafetamine (MDMA), among other concerns raised ahead of an advisory committee meeting on a potential drug indication for post-traumatic stress disorder. Annual healthcare costs.

Heart Disease 98

Heart Disease 98

DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product. Five Medicare Administrative Contractors (MACs), CGS, NGS, Noridian, Palmetto GBA, and WPS, released draft Local Coverage Determinations (LCD) for Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaqu

Medicare 104

Medicare Plaque Reimbursement Cardiovascular Disease 104

HCPLive

JUNE 4, 2024

In an interview with HCPLive, DelRosso spoke about the 1-year plans of the "Count on Sleep" OSA project.

105

105

JAMA Cardiology

JUNE 4, 2024

The United Nations Sustainable Development Goals for 2030 include a strong focus on health, wherein it is stated “…to extend life expectancy for all, we must achieve universal health coverage and access to quality health care. No one must be left behind.” While some progress has been made, rheumatic heart disease (RHD) provides a tragic example of how, in some ways, we are far from this idealistic goal.

Heart Disease 80

Heart Disease 80

Circulation

JUNE 4, 2024

Circulation, Ahead of Print. BACKGROUND:Cardiovascular disease and stroke are common and costly, and their prevalence is rising. Forecasts on the prevalence of risk factors and clinical events are crucial.METHODS:Using the 2015 to March 2020 National Health and Nutrition Examination Survey and 2015 to 2019 Medical Expenditure Panel Survey, we estimated trends in prevalence for cardiovascular risk factors based on adverse levels of Life’s Essential 8 and clinical cardiovascular disease and stroke

Risk Factors 81

Risk Factors Cardiovascular Disease Strokes Stroke 81

HeartRhythm

JUNE 4, 2024

Energy drinks potentially can trigger life-threatening cardiac arrhythmias. It has been postulated that the highly stimulating and unregulated ingredients alter heart rate, blood pressure, cardiac contractility, and cardiac repolarization in a potentially proarrhythmic manner.

Cardiac Arrest 76

Cardiac Arrest Blood Pressure Arrhythmia 76

Circulation

JUNE 4, 2024

Circulation, Ahead of Print. BACKGROUND:Quantifying the economic burden of cardiovascular disease and stroke over the coming decades may inform policy, health system, and community-level interventions for prevention and treatment.METHODS:We used nationally representative health, economic, and demographic data to project health care costs attributable to key cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia) and conditions (coronary heart disease, stroke, heart failure, at

Cardiovascular Disease 75

Cardiovascular Disease Strokes Stroke Risk Factors 75

HeartRhythm

JUNE 4, 2024

In patients with a history of stroke or those at high risk of developing stroke, a continuous rhythm monitoring strategy using implantable loop recorders (ILR) is often performed to screen for atrial fibrillation (AF).

Atrial Fibrillation 75

Atrial Fibrillation Strokes Stroke 75

JAMA Cardiology

JUNE 4, 2024

This cohort study evaluates which emergency medical services practices are associated with favorable neurological survival for out-of-hospital cardiac arrest using data from the Cardiac Arrest Registry to Enhance Survival.

Cardiac Arrest 71

Cardiac Arrest Hospital 71

HCPLive

JUNE 4, 2024

The month of May 2024 featured several notable studies in the field of dermatology, concerning topics such as a potential eczema flare vaccine, mobile versus in-person health, and skin cancer risk.

Cancer 59

Cancer 59

American College of Cardiology

JUNE 4, 2024

Neijenhuis et al. and Fusco et al. addressed the safety, tolerability, and outcomes of patients with adult congenital heart disease (ACHD) treated with sodium-glucose cotransporter 2 inhibitors (SGLT2i).

Congenital Heart Disease 64

Congenital Heart Disease Congenital Heart Disease Outcomes 64

American Heart News - Stroke News

JUNE 4, 2024

DALLAS, 4 de junio de 2024 — Significativas barreras impiden o retrasan el tratamiento para muchos pacientes que han sufrido un derrame cerebral, incluidos los largos tiempos de viaje a hospitales especializados y la falta de disponibilidad de.

58

58

American College of Cardiology

JUNE 4, 2024

In this interview, Michael D. Shapiro, DO, FACC and Roger S. Blumenthal MD, FACC explore CAC scoring and the role of calcium detection in tailoring patient care, personalized risk assessment, and the prevention of future cardiac events.

Patient Care 63

Patient Care Article 63

HCPLive

JUNE 4, 2024

The approvals were based on data from well-controlled studies of the drug in adult patients with PsA and RA.

Pediatrics 75

Pediatrics 75

American Heart News - Heart News

JUNE 4, 2024

Prohibida su publicación hasta las 4 a. m., CT/5 a. m., ET del martes, 4 de junio de 2024 DALLAS, 4 de junio de 2024 — Impulsados por una población mayor y más diversa, junto con un aumento significativo de los factores de riesgo, como la presión.

52

52

HCPLive

JUNE 4, 2024

This review of May 2024 covered several notable topics in the pulmonary health field, including research into vaping, lung abnormalities, and treatment of COPD.

Pulmonary 59

Pulmonary Research 59

Journal of Cardiothoracic Surgery

JUNE 4, 2024

Aberrant left coronary artery from pulmonary artery (ALCAPA) is a very rare congenital heart defect. Its coexistence with patent ductus arteriosus (PDA) is extremely rare. The high pr.

Pulmonary 52

Pulmonary Congenital 52

HCPLive

JUNE 4, 2024

Our endocrinology month in review for May 2024 highlights pipeline news in endocrinology and spotlights our coverage of the landmark FLOW trial from ERA 2024.

59

59

Journal of Cardiothoracic Surgery

JUNE 4, 2024

Pre-operative coronary angiography and concomitant, planned coronary artery bypass are infrequently performed with type A aortic dissection repair. We present a case in which pre-operative coronary computed to.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Aortic 52

Frontiers in Cardiovascular Medicine

JUNE 4, 2024

Left atrial appendage occluder (LAAO) dislodgement with embolization is a rare occurrence. If the LAAO migrates into the left atrium or ventricle, it can lead to acute heart failure or even death in a person, necessitating urgent surgical intervention. Currently, most cases of LAAO dislodgement are managed through open-heart surgery, while percutaneous retrieval of the LAAO has been reported only in a few cases with limited associated experience.

Open-Heart Surgery 52

Open-Heart Surgery Embolism Innovation Article 52

The American Journal of Cardiology

JUNE 4, 2024

Publication date: Available online 4 June 2024 Source: The American Journal of Cardiology Author(s): Francesco Bianchini, Emiliano Bianchini, Enrico Romagnoli, Cristina Aurigemma, Andrea Zito, Marco Busco, Marialisa Nesta, Piergiorgio Bruno, Domenico Laezza, Nicole Giambusso, Luigi Natale, Gemma Pelargonio, Francesco Burzotta, Carlo Trani

Aortic valve 52

Aortic valve Pacemaker Aortic 52

HCPLive

JUNE 4, 2024

cfPWV values were significantly higher in patients with PsA compared with controls, even after adjusting for confounders.

Aortic 64

Aortic 64

American College of Cardiology

JUNE 4, 2024

The goal of the Dual vs. Single DCCV trial was to determine the efficacy and safety of dual direct-current cardioversion (DCCV) compared with single DCCV in patients with obesity and atrial fibrillation (AF) undergoing elective electrical cardioversion.

Obesity 56

Obesity Atrial Fibrillation Article 56

HCPLive

JUNE 4, 2024

The May 2024 gastroenterology month in review spotlights top research from Digestive Disease Week 2024 and the FDA approval of ColoSense.

Research 59

Research 59

Becker's Hospital Review - Cardiology

JUNE 4, 2024

"Discover the new stroke telehealth certification from the American Heart Association, designed to standardize training and improve care for patients in need.

Certification 52

Certification Stroke Strokes 52